AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2018
Apr 5, 2018
35021_dirs_2018-04-05_9a7354b6-f72f-4015-9a0d-0c25a8ccedbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-04-01
Reporting Person: POSNER BRIAN M (Chief Financial Officer)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4